Because FADS1 downregulation in normal melanocytes induces cell cycle arrest and cell death via ROS generation and mitochondria-mediated apoptosis, we propose that strategies aimed at restoring FADS1 expression in affected melanocytes could potentially improve therapeutic outcomes in patients with vitiligo. Here, FADS1 is linked to vitiligo.